SCHEMBL29181799

SCHEMBL29181799

CO/N=C1/CCCc2cc(OC)cc(Cl)c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
MAPT P10636 3/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
KDM4E B2RXH2 2/20 0.33
KIT P10721 1/20 0.33
PDGFRA P16234 1/20 0.33
FLT4 P35916 1/20 0.33
KDR P35968 1/20 0.33
FLT3 P36888 1/20 0.33
EGFR P00533 4/20 0.33
XDH P47989 2/20 0.33
MEN1 O00255 1/20 0.33
NFE2L2 Q16236 1/20 0.33
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
MAOA P21397 1/20 0.32
BCL2 P10415 1/20 0.32
HTR6 P50406 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24755438 1.00 ALDH1A1 (0.35) ALDH1A1MAPTMAPK1KMT2ATDP1
SCHEMBL30048852 1.00 ALDH1A1 (0.35) ALDH1A1MAPTMAPK1KMT2ATDP1
SCHEMBL24755442 0.86 KDM4E (0.33) ALDH1A1MAPTKMT2ATDP1KDM4E
SCHEMBL31650059 0.83 ALDH1A1 (0.36) ALDH1A1MAPTMAPK1KMT2ATDP1
SCHEMBL25642895 0.83 ALDH1A1 (0.36) ALDH1A1MAPTMAPK1KMT2ATDP1
SCHEMBL31048409 0.83 ALDH1A1 (0.36) ALDH1A1MAPTMAPK1KMT2ATDP1
SCHEMBL24755482 0.76 EGFR (0.41) ALDH1A1KMT2AKDM4EKITPDGFRA
SCHEMBL30049403 0.76 EGFR (0.41) ALDH1A1KMT2AKDM4EKITPDGFRA
SCHEMBL15129412 0.76 HTT (0.35) HTT
SCHEMBL18204519 0.75 MAPT (0.36) ALDH1A1MAPTKMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813306-A Heterocyclic compounds as KRAS inhibitors, their preparation and therapeutic use 上海科州药物研发有限公司 2024-04-02 CN disclosed